 | • レポートコード：GIR-107A12295 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子組み換え療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子組み換え療法の種類別市場規模（遺伝子治療、遺伝子組み換え細胞治療、RNA治療、遺伝子編集）、用途別市場規模（病院、診断・試験研究所、学術・研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子組み換え療法の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：4D Molecular Therapeutics、Abeona Therapeutics、Allergan、American Gene Technologies、Merck Millipore、AbbVie ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：遺伝子治療、遺伝子組み換え細胞治療、RNA治療、遺伝子編集 ・用途別分析2016年-2026年：病院、診断・試験研究所、学術・研究機関、その他 ・遺伝子組み換え療法の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子組み換え療法のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子組み換え療法のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子組み換え療法の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子組み換え療法の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Genetic Modification Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Genetic Modification Therapies size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Genetic Modification Therapies market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Genetic Modification Therapies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Gene Therapies
Genetically Modified Cell Therapies
RNA Therapies
Gene Editing
Market segment by Application, can be divided into
Hospitals
Diagnostics and Testing Laboratories
Academic and Research Organizations
Others
Market segment by players, this report covers
4D Molecular Therapeutics
Abeona Therapeutics
Allergan
American Gene Technologies
Merck Millipore
AbbVie
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Genetic Modification Therapies
1.2 Classification of Genetic Modification Therapies by Type
1.2.1 Overview: Global Genetic Modification Therapies Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Genetic Modification Therapies Revenue Market Share by Type in 2020
1.2.3 Gene Therapies
1.2.4 Genetically Modified Cell Therapies
1.2.5 RNA Therapies
1.2.6 Gene Editing
1.3 Global Genetic Modification Therapies Market by Application
1.3.1 Overview: Global Genetic Modification Therapies Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Diagnostics and Testing Laboratories
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Global Genetic Modification Therapies Market Size & Forecast
1.5 Global Genetic Modification Therapies Market Size and Forecast by Region
1.5.1 Global Genetic Modification Therapies Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Genetic Modification Therapies Market Size by Region, (2016-2021)
1.5.3 North America Genetic Modification Therapies Market Size and Prospect (2016-2026)
1.5.4 Europe Genetic Modification Therapies Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Genetic Modification Therapies Market Size and Prospect (2016-2026)
1.5.6 South America Genetic Modification Therapies Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Genetic Modification Therapies Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genetic Modification Therapies Market Drivers
1.6.2 Genetic Modification Therapies Market Restraints
1.6.3 Genetic Modification Therapies Trends Analysis
2 Company Profiles
2.1 4D Molecular Therapeutics
2.1.1 4D Molecular Therapeutics Details
2.1.2 4D Molecular Therapeutics Major Business
2.1.3 4D Molecular Therapeutics Genetic Modification Therapies Product and Solutions
2.1.4 4D Molecular Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 4D Molecular Therapeutics Recent Developments and Future Plans
2.2 Abeona Therapeutics
2.2.1 Abeona Therapeutics Details
2.2.2 Abeona Therapeutics Major Business
2.2.3 Abeona Therapeutics Genetic Modification Therapies Product and Solutions
2.2.4 Abeona Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Abeona Therapeutics Recent Developments and Future Plans
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business
2.3.3 Allergan Genetic Modification Therapies Product and Solutions
2.3.4 Allergan Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Allergan Recent Developments and Future Plans
2.4 American Gene Technologies
2.4.1 American Gene Technologies Details
2.4.2 American Gene Technologies Major Business
2.4.3 American Gene Technologies Genetic Modification Therapies Product and Solutions
2.4.4 American Gene Technologies Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 American Gene Technologies Recent Developments and Future Plans
2.5 Merck Millipore
2.5.1 Merck Millipore Details
2.5.2 Merck Millipore Major Business
2.5.3 Merck Millipore Genetic Modification Therapies Product and Solutions
2.5.4 Merck Millipore Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Merck Millipore Recent Developments and Future Plans
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Genetic Modification Therapies Product and Solutions
2.6.4 AbbVie Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 AbbVie Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Genetic Modification Therapies Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Genetic Modification Therapies Players Market Share
3.2.2 Top 10 Genetic Modification Therapies Players Market Share
3.2.3 Market Competition Trend
3.3 Genetic Modification Therapies Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Genetic Modification Therapies Revenue and Market Share by Type (2016-2021)
4.2 Global Genetic Modification Therapies Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Genetic Modification Therapies Revenue Market Share by Application (2016-2021)
5.2 Genetic Modification Therapies Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Genetic Modification Therapies Revenue by Type (2016-2026)
6.2 North America Genetic Modification Therapies Revenue by Application (2016-2026)
6.3 North America Genetic Modification Therapies Market Size by Country
6.3.1 North America Genetic Modification Therapies Revenue by Country (2016-2026)
6.3.2 United States Genetic Modification Therapies Market Size and Forecast (2016-2026)
6.3.3 Canada Genetic Modification Therapies Market Size and Forecast (2016-2026)
6.3.4 Mexico Genetic Modification Therapies Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Genetic Modification Therapies Revenue by Type (2016-2026)
7.2 Europe Genetic Modification Therapies Revenue by Application (2016-2026)
7.3 Europe Genetic Modification Therapies Market Size by Country
7.3.1 Europe Genetic Modification Therapies Revenue by Country (2016-2026)
7.3.2 Germany Genetic Modification Therapies Market Size and Forecast (2016-2026)
7.3.3 France Genetic Modification Therapies Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Genetic Modification Therapies Market Size and Forecast (2016-2026)
7.3.5 Russia Genetic Modification Therapies Market Size and Forecast (2016-2026)
7.3.6 Italy Genetic Modification Therapies Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Genetic Modification Therapies Revenue by Type (2016-2026)
8.2 Asia-Pacific Genetic Modification Therapies Revenue by Application (2016-2026)
8.3 Asia-Pacific Genetic Modification Therapies Market Size by Region
8.3.1 Asia-Pacific Genetic Modification Therapies Revenue by Region (2016-2026)
8.3.2 China Genetic Modification Therapies Market Size and Forecast (2016-2026)
8.3.3 Japan Genetic Modification Therapies Market Size and Forecast (2016-2026)
8.3.4 South Korea Genetic Modification Therapies Market Size and Forecast (2016-2026)
8.3.5 India Genetic Modification Therapies Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Genetic Modification Therapies Market Size and Forecast (2016-2026)
8.3.7 Australia Genetic Modification Therapies Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Genetic Modification Therapies Revenue by Type (2016-2026)
9.2 South America Genetic Modification Therapies Revenue by Application (2016-2026)
9.3 South America Genetic Modification Therapies Market Size by Country
9.3.1 South America Genetic Modification Therapies Revenue by Country (2016-2026)
9.3.2 Brazil Genetic Modification Therapies Market Size and Forecast (2016-2026)
9.3.3 Argentina Genetic Modification Therapies Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Genetic Modification Therapies Revenue by Type (2016-2026)
10.2 Middle East & Africa Genetic Modification Therapies Revenue by Application (2016-2026)
10.3 Middle East & Africa Genetic Modification Therapies Market Size by Country
10.3.1 Middle East & Africa Genetic Modification Therapies Revenue by Country (2016-2026)
10.3.2 Turkey Genetic Modification Therapies Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Genetic Modification Therapies Market Size and Forecast (2016-2026)
10.3.4 UAE Genetic Modification Therapies Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Genetic Modification Therapies Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Genetic Modification Therapies Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Genetic Modification Therapies Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Genetic Modification Therapies Revenue (USD Million) by Region (2016-2021)
Table 5. Global Genetic Modification Therapies Revenue Market Share by Region (2021-2026)
Table 6. 4D Molecular Therapeutics Corporate Information, Head Office, and Major Competitors
Table 7. 4D Molecular Therapeutics Major Business
Table 8. 4D Molecular Therapeutics Genetic Modification Therapies Product and Solutions
Table 9. 4D Molecular Therapeutics Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Abeona Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. Abeona Therapeutics Major Business
Table 12. Abeona Therapeutics Genetic Modification Therapies Product and Solutions
Table 13. Abeona Therapeutics Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Allergan Corporate Information, Head Office, and Major Competitors
Table 15. Allergan Major Business
Table 16. Allergan Genetic Modification Therapies Product and Solutions
Table 17. Allergan Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. American Gene Technologies Corporate Information, Head Office, and Major Competitors
Table 19. American Gene Technologies Major Business
Table 20. American Gene Technologies Genetic Modification Therapies Product and Solutions
Table 21. American Gene Technologies Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Merck Millipore Corporate Information, Head Office, and Major Competitors
Table 23. Merck Millipore Major Business
Table 24. Merck Millipore Genetic Modification Therapies Product and Solutions
Table 25. Merck Millipore Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. AbbVie Corporate Information, Head Office, and Major Competitors
Table 27. AbbVie Major Business
Table 28. AbbVie Genetic Modification Therapies Product and Solutions
Table 29. AbbVie Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Genetic Modification Therapies Revenue (USD Million) by Players (2019-2021)
Table 31. Global Genetic Modification Therapies Revenue Share by Players (2019-2021)
Table 32. Breakdown of Genetic Modification Therapies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Genetic Modification Therapies Players Head Office, Products and Services Provided
Table 34. Genetic Modification Therapies Mergers & Acquisitions in the Past Five Years
Table 35. Genetic Modification Therapies New Entrants and Expansion Plans
Table 36. Global Genetic Modification Therapies Revenue (USD Million) by Type (2016-2021)
Table 37. Global Genetic Modification Therapies Revenue Share by Type (2016-2021)
Table 38. Global Genetic Modification Therapies Revenue Forecast by Type (2021-2026)
Table 39. Global Genetic Modification Therapies Revenue by Application (2016-2021)
Table 40. Global Genetic Modification Therapies Revenue Forecast by Application (2021-2026)
Table 41. North America Genetic Modification Therapies Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Genetic Modification Therapies Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Genetic Modification Therapies Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Genetic Modification Therapies Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Genetic Modification Therapies Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Genetic Modification Therapies Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Genetic Modification Therapies Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Genetic Modification Therapies Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Genetic Modification Therapies Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Genetic Modification Therapies Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Genetic Modification Therapies Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Genetic Modification Therapies Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Genetic Modification Therapies Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Genetic Modification Therapies Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Genetic Modification Therapies Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Genetic Modification Therapies Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Genetic Modification Therapies Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Genetic Modification Therapies Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Genetic Modification Therapies Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Genetic Modification Therapies Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Genetic Modification Therapies Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Genetic Modification Therapies Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Genetic Modification Therapies Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Genetic Modification Therapies Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Genetic Modification Therapies Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Genetic Modification Therapies Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Genetic Modification Therapies Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Genetic Modification Therapies Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Genetic Modification Therapies Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Genetic Modification Therapies Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Genetic Modification Therapies Picture
Figure 2. Global Genetic Modification Therapies Revenue Market Share by Type in 2020
Figure 3. Gene Therapies
Figure 4. Genetically Modified Cell Therapies
Figure 5. RNA Therapies
Figure 6. Gene Editing
Figure 7. Genetic Modification Therapies Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Diagnostics and Testing Laboratories Picture
Figure 10. Academic and Research Organizations Picture
Figure 11. Others Picture
Figure 12. Global Genetic Modification Therapies Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Genetic Modification Therapies Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Genetic Modification Therapies Revenue Market Share by Region (2016-2026)
Figure 15. Global Genetic Modification Therapies Revenue Market Share by Region in 2020
Figure 16. North America Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Genetic Modification Therapies Market Drivers
Figure 22. Genetic Modification Therapies Market Restraints
Figure 23. Genetic Modification Therapies Market Trends
Figure 24. 4D Molecular Therapeutics Recent Developments and Future Plans
Figure 25. Abeona Therapeutics Recent Developments and Future Plans
Figure 26. Allergan Recent Developments and Future Plans
Figure 27. American Gene Technologies Recent Developments and Future Plans
Figure 28. Merck Millipore Recent Developments and Future Plans
Figure 29. AbbVie Recent Developments and Future Plans
Figure 30. Global Genetic Modification Therapies Revenue Share by Players in 2020
Figure 31. Genetic Modification Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Genetic Modification Therapies Revenue Market Share in 2020
Figure 33. Global Top 10 Players Genetic Modification Therapies Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Genetic Modification Therapies Revenue Share by Type in 2020
Figure 36. Global Genetic Modification Therapies Market Share Forecast by Type (2021-2026)
Figure 37. Global Genetic Modification Therapies Revenue Share by Application in 2020
Figure 38. Global Genetic Modification Therapies Market Share Forecast by Application (2021-2026)
Figure 39. North America Genetic Modification Therapies Sales Market Share by Type (2016-2026)
Figure 40. North America Genetic Modification Therapies Sales Market Share by Application (2016-2026)
Figure 41. North America Genetic Modification Therapies Revenue Market Share by Country (2016-2026)
Figure 42. United States Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Genetic Modification Therapies Sales Market Share by Type (2016-2026)
Figure 46. Europe Genetic Modification Therapies Sales Market Share by Application (2016-2026)
Figure 47. Europe Genetic Modification Therapies Revenue Market Share by Country (2016-2026)
Figure 48. Germany Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Genetic Modification Therapies Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Genetic Modification Therapies Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Genetic Modification Therapies Revenue Market Share by Region (2016-2026)
Figure 56. China Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Genetic Modification Therapies Sales Market Share by Type (2016-2026)
Figure 63. South America Genetic Modification Therapies Sales Market Share by Application (2016-2026)
Figure 64. South America Genetic Modification Therapies Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Genetic Modification Therapies Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Genetic Modification Therapies Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Genetic Modification Therapies Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Genetic Modification Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
世界の遺伝子組み換え市場予測（～2024年）：企業別、地域別、種類・用途別 Genetic modification is the direct manipulation of an organism's genes using biotechnology. Scope of the Report: The global Genetic Modification market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The …- 世界のがん治療用遺伝子治療市場予測（～2024年） Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functi…
- 世界の不妊治療市場 2021：企業別、地域別、種類・用途別 The Infertility Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の重症筋無力症治療市場 2021：企業別、地域別、種類・用途別 The Myasthenia Gravis Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の緑内障手術療法市場 2021：企業別、地域別、種類・用途別 The Glaucoma Surgery Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…